{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:04:07Z","timestamp":1781111047168,"version":"3.54.1"},"reference-count":44,"publisher":"Tech Science Press","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2025]]},"DOI":"10.32604\/or.2025.065547","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T03:21:16Z","timestamp":1750821676000},"page":"1895-1908","source":"Crossref","is-referenced-by-count":1,"title":["Implementation of a Pediatric Oncology Precision Medicine Clinic to Personalize Approaches for Diagnosing and Treating Solid Tumors"],"prefix":"10.32604","volume":"33","author":[{"given":"Madeline","family":"Keane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Wojciechowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Zumwalt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Sandfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anish","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"101733","DOI":"10.1016\/j.canep.2020.101733","article-title":"Childhood cancer: survival, treatment modalities, late effects and improvements over time","volume":"71","author":"Erdmann","year":"2021","journal-title":"Cancer Epidemiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.3390\/cancers13174324","article-title":"The landscape of pediatric precision oncology: program design, actionable alterations, and clinical trial development","volume":"13","author":"Langenberg","year":"2021 Aug 27","journal-title":"Cancers"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e26288","DOI":"10.1002\/pbc.26288","article-title":"Precision medicine in pediatric oncology: lessons learned and next steps","volume":"64","author":"Mody","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1700391","DOI":"10.1183\/13993003.00391-2017","article-title":"What is precision medicine?","volume":"50","author":"K\u00f6nig","year":"2017","journal-title":"Eur Respir J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1463962","DOI":"10.3389\/fmolb.2024.1463962","article-title":"Editorial: systems and network approaches to precision medicine and healthcare","volume":"11","author":"Kurnat-Thoma","year":"2024","journal-title":"Front Mol Biosci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1200\/PO.20.00405","article-title":"Clinical utility of precision medicine in pediatric oncology: a systematic review","volume":"5","author":"Lee","year":"2021 Jun","journal-title":"JCO Precis Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MOP.0000000000001422","article-title":"The childhood cancer data initiative: enabling data sharing to drive research advances and transform pediatric cancer diagnosis and treatment","volume":"37","author":"Jagu","year":"2025","journal-title":"Curr Opin Pediatr"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/MOP.0000000000001198","article-title":"Progress in precision therapy in pediatric oncology","volume":"35","author":"O\u2019Donohue","year":"2022 Nov 15","journal-title":"Curr Opin Pediatr"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1245\/s10434-025-17051-z","article-title":"ASO author reflections: current status and future directions of ewing sarcoma research","volume":"32","author":"Wu","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12032-025-02629-0","article-title":"From conventional to cutting edge: an exploration of osteosarcoma treatments","volume":"42","author":"Sellers","year":"2025","journal-title":"Med Oncol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"i213","DOI":"10.1136\/bmj.i213","article-title":"US president endorses \u201cmoonshot\u201d effort to cure cancer","volume":"352","author":"McCarthy","year":"2016","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3390\/cancers17081292","article-title":"The clinical utility of next-generation sequencing in childhood and adolescent\/young adult solid tumors: a systematic review and meta-analysis","volume":"17","author":"Katz","year":"2025","journal-title":"Cancers"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejca.2021.09.042","article-title":"Circulating tumour DNA sequencing to determine therapeutic response and identify tumour heterogeneity in patients with paediatric solid tumours","volume":"162","author":"Stankunaite","year":"2022 Feb 1","journal-title":"Eur J Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e2023062850","DOI":"10.1542\/peds.2023-062850","article-title":"A communication and decision-making framework for pediatric precision medicine","volume":"153","author":"Greene","year":"2024 Apr","journal-title":"Pediatrics"},{"key":"ref15","year":"2011","journal-title":"The national academies collection: reports funded by national institutes of health. toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1358\/dot.1999.35.12.564040","article-title":"Trastuzumab, a humanized anti-HER2 monoclonal antibody, for the treatment of breast cancer","volume":"35","author":"Albanell","year":"1999","journal-title":"Drugs Today"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1634\/theoncologist.7-5-390","article-title":"Gleevec for the treatment of chronic myelogenous leukemia: U.S. Food and Drug Administration regulatory mechanisms, accelerated approval, and orphan drug status","volume":"7","author":"Cohen","year":"2002","journal-title":"Oncologist"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/s41591-024-02848-4","article-title":"Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancers","volume":"30","author":"Acanda De La Rocha","year":"2024","journal-title":"Nat Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3389\/fonc.2018.00163","article-title":"Past, present, and future of rituximab\u2014the world\u2019s first oncology monoclonal antibody therapy","volume":"8","author":"Pierpont","year":"2018 Jun 4","journal-title":"Front Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e85245","DOI":"10.1371\/journal.pone.0085245","article-title":"Network meta-analysis of erlotinib, gefitinib, afatinib and icotinib in patients with advanced non-small-cell lung cancer harboring EGFR mutations","volume":"9","author":"Liang","year":"2014 Feb 12","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ejca.2020.06.028","article-title":"Spotlight on the treatment of infantile fibrosarcoma in the era of neurotrophic tropomyosin receptor kinase inhibitors: international consensus and remaining controversies","volume":"137","author":"Orbach","year":"2020","journal-title":"Eur J Cancer"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e000023","DOI":"10.1136\/esmoopen-2015-000023","article-title":"NTRK gene fusions as novel targets of cancer therapy across multiple tumour types","volume":"1","author":"Amatu","year":"2016","journal-title":"ESMO Open"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.3390\/cancers16193395","article-title":"Tissue-agnostic targeting of neurotrophic tyrosine receptor kinase fusions: current approvals and future directions","volume":"16","author":"Gouda","year":"2024 Oct 4","journal-title":"Cancers"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41586-021-04140-8","article-title":"Mechanism for the activation of the anaplastic lymphoma kinase receptor","volume":"600","author":"Reshetnyak","year":"2021","journal-title":"Nature"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1158\/1078-0432.CCR-16-0115","article-title":"Precision medicine in pediatric oncology: translating genomic discoveries into optimized therapies","volume":"23","author":"Tran","year":"2017 Jun 9","journal-title":"Clinic Cancer Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3390\/hematolrep15020025","article-title":"Molecular tumor boards: the next step towards precision therapy in cancer care","volume":"15","author":"Liu","year":"2023","journal-title":"Hematol Rep"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/MPH.0000000000002485","article-title":"Lessons learned: utilization of a reference laboratory for targeted sequencing of pediatric tumors at a single institution","volume":"45","author":"Swilling","year":"2023","journal-title":"J Pediat Hematol\/Oncol"},{"key":"ref28","unstructured":"NCI-COG Pediatric MATCH Precision Medicine Clinical Trial cancer.gov: National Cancer Institute; 2024. [cited 2025 Jun 2]. Available from: https:\/\/www.cancer.gov\/research\/infrastructure\/clinical-trials\/nci-supported\/pediatric-match."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s12909-024-06603-8","article-title":"Role of medical students in a pediatric oncology precision medicine clinic","volume":"25","author":"Schluterman","year":"2025","journal-title":"BMC Med Educ"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3390\/hemato5010007","article-title":"Immune checkpoint inhibition in pediatric oncology patients: a single-institution experience","volume":"5","author":"Wojciechowska","year":"2024","journal-title":"Hemato"},{"key":"ref31","year":"2017","journal-title":"NIH Turning discovery into health"},{"key":"ref32","unstructured":"Heger M. Despite actionable results, cancer sequencing projects struggle to get patients on targeted drugs. GenomeWeb. 2017 [cited 2025 Jun 2]. Available from: https:\/\/www.genomeweb.com\/cancer\/despite-actionable-results-cancer-sequencing-projects-struggle-get-patients-targeted-drugs."},{"key":"ref33","first-page":"135","article-title":"The American Cancer Society\u2019s facts & figures: 2020 edition","volume":"11","author":"Viale","year":"2020","journal-title":"J Adv Pract Oncol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/fampra\/cmq035","article-title":"The primary care physician role in cancer genetics: a qualitative study of patient experience","volume":"27","author":"Miller","year":"2010","journal-title":"Family Practice"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41591-019-0383-9","article-title":"Developmental origins and emerging therapeutic opportunities for childhood cancer","volume":"25","author":"Filbin","year":"2019","journal-title":"Nat Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1126\/science.aaw3535","article-title":"The genomic landscape of pediatric cancers: implications for diagnosis and treatment","volume":"363","author":"Sweet-Cordero","year":"2019 Mar 15","journal-title":"Science"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"djw274","DOI":"10.1093\/jnci\/djw274","article-title":"Target and agent prioritization for the children\u2019s oncology group-national cancer institute pediatric MATCH trial","volume":"109","author":"Allen","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"189250","DOI":"10.1016\/j.bbcan.2024.189250","article-title":"Precision oncology: using cancer genomics for targeted therapy advancements","volume":"1880","author":"Avci","year":"2024 Dec 17","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1002\/cncr.30724","article-title":"Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues","volume":"123","author":"Majzner","year":"2017 Jun 13","journal-title":"Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1200\/JCO.21.02285","article-title":"Basket trials: review of current practice and innovations for future trials","volume":"40","author":"Hobbs","year":"2022","journal-title":"J Clin Oncol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.phoj.2019.03.002","article-title":"Long term effects of therapy among childhood cancer survivors treated in the last two decades","volume":"4","author":"AbdelHameid","year":"2019 May 01","journal-title":"Pediatr Hematol Oncol J"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1470-2045(19)30800-9","article-title":"Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study","volume":"21","author":"Suh","year":"2020 Mar","journal-title":"Lancet Oncol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1017\/pcm.2022.14","article-title":"Advancing precision medicine in paediatrics: past, present and future","volume":"1","author":"Elzagallaai","year":"2023","journal-title":"Camb Prism Precis Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"17145","DOI":"10.1038\/s41598-020-73028-w","article-title":"Gap between pediatric and adult approvals of molecular targeted drugs","volume":"10","author":"Nishiwaki","year":"2020 Oct 13","journal-title":"Sci Rep"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.techscience.cn\/files\/or\/2025\/TSP_OR-33-8\/OncolRes-33-08-65547\/OncolRes-33-65547.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T01:54:20Z","timestamp":1763344460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v33n8\/63056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":44,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2025.065547","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}